← Back to Search

Other

Healthy Eating for Aging

N/A
Waitlist Available
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy male or non-pregnant pre-menopausal female, 25-45 years of age, inclusive
Be between 18 and 65 years old
Must not have
Cancer requiring treatment in the past 5 years (except for non-melanoma skin cancer)
Low Bone mineral density z-score < -2.0 of the hip (total hip or femoral neck) or lumbar spine (L1-L4)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months

Summary

This trial will test if healthy eating can slow down the aging process in young people without obesity. #healthyeating

Who is the study for?
The DiAL Health Research Study is for healthy individuals aged 25-45 with a BMI between 22 and below 30, who have maintained a stable weight recently, wake up early, and don't use chronic medications. Excluded are those with serious health conditions, pregnant or lactating women, heavy smokers or drinkers, extreme athletes, and people with unconventional eating habits.
What is being tested?
This study tests the effectiveness of different dietary interventions aimed at slowing aging processes in young adults without obesity. It's a pilot trial with five groups to see which diet might help improve treatment compliance and support weight loss while promoting healthier aging.
What are the potential side effects?
Since this is a dietary intervention trial focused on healthy individuals without obesity to slow aging mechanisms rather than testing drugs or medical procedures, side effects may be minimal but could include changes in energy levels or digestive discomfort depending on the specific diets tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a healthy adult between 25 and 45 years old and not pregnant.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have needed treatment for cancer other than non-melanoma skin cancer in the last 5 years.
Select...
My bone density test shows a score lower than -2.0 in my hip or spine.
Select...
I have asthma or sleep apnea.
Select...
I work night shifts more than once a week or will travel across more than 2 time zones soon.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intervention satisfaction ratings
Percent CR (CR groups only)
Percent adherence to TRE (TRE groups only)

Trial Design

5Treatment groups
Active Control
Placebo Group
Group I: Traditional CRActive Control1 Intervention
A 25% calorie restriction (CR) intervention delivered via traditional in-person sessions.
Group II: Adaptive CRActive Control1 Intervention
A 25% calorie restriction (CR) intervention delivered via a remote, adaptive, and technology-driven intervention program.
Group III: Traditional TREActive Control1 Intervention
An eight-hour time restricted eating (TRE) intervention delivered via traditional in-person sessions.
Group IV: Adaptive TREActive Control1 Intervention
An eight-hour time restricted eating (TRE) intervention delivered via a remote, adaptive, and technology driven intervention program.
Group V: ad libitum ControlPlacebo Group1 Intervention
No treatment control condition.

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
309 Previous Clinical Trials
179,828 Total Patients Enrolled
5 Trials studying Aging
195 Patients Enrolled for Aging

Media Library

DiAL Health Research Study (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05549362 — N/A
Aging Research Study Groups: ad libitum Control, Traditional CR, Adaptive CR, Traditional TRE, Adaptive TRE
Aging Clinical Trial 2023: DiAL Health Research Study Highlights & Side Effects. Trial Name: NCT05549362 — N/A
DiAL Health Research Study (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05549362 — N/A
Aging Patient Testimony for trial: Trial Name: NCT05549362 — N/A
~4 spots leftby Feb 2025